Vertex Pharmaceuticals Inc (MIL:1VRTX)
€ 441.05 -2.05 (-0.46%) Market Cap: 112.08 Bil Enterprise Value: 107.49 Bil PE Ratio: 0 PB Ratio: 7.54 GF Score: 73/100

Vertex Pharmaceuticals Inc at Wells Fargo Healthcare Conference Transcript

Sep 09, 2022 / 03:00PM GMT
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

Thank you very much for joining us today. So for this keynote, we have Vertex' CEO, Reshma Kewalramani with us. Thank you, Reshma for joining us today.

Reshma Kewalramani
Vertex Pharmaceuticals Incorporated - CEO, President & Director

Mohit, thank you for the invitation.

Questions & Answers

Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

Great. So I think the first question I always wanted to ask, like you have been in this CEO role -- you have been with this company longer, but in the CEO role for last over 2 years now. And so when you think about the evolution of the company in the last couple of years, the pipeline and everything and you've launched TRIKAFTA really well. So when you think about the progress you have made on base business and more importantly, on pipeline, so how do you see Vertex as it trends now versus 2 years back? And how it is poised for the future with that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot